Known risk factors for bleeding during anticoagulant treatment are largely the same as those predicting thromboembolic events in patients with atrial fibrillation (AF). Our objective was to investigate how to maximize the likelihood of avoiding both stroke and bleeding.
|Number of pages||10|
|Early online date||18 Apr 2012|
|Publication status||Published - 18 Apr 2012|